Please login to the form below

INFOSHEET 02: Improving diversity in your patient recruitment strategy

As inclusion and diversity advocates, we design and implement recruitment strategies that break down participant barriers.

As ethnic and religious minorities remain under-represented in clinical studies globally, and enrolment remains your biggest challenge, the connection between the two shouldn’t go unnoticed.

Barriers to recruitment can be economic, linguistic, cultural, religious or physical. And in many cases, patients are referred by doctors or medical centres, which have a higher percentage of certain demographics than others. But with regulatory bodies around the world increasingly asking for evidence of drug safety and effectiveness in diverse populations, it’s vital to address these barriers in your clinical study design.

How a lack of diversity affects outcomes

Differences between people, such as:

  • age
  • gender
  • weight
  • ethnicity
  • geographical location

can affect clinical outcomes. Different groups may need alternative drug dosages, experience completely different results, and have distinctive side effects. Without a diverse participant pool, these metrics can’t be fully explored, meaning outcomes will be unknown.

Widen your participant pool to improve enrolment targets

Improving diversity in clinical studies brings huge benefits. For research companies, facilitating minority patients to enrol on your study means you’ll have a much broader patient pool to recruit participants from.

Help improve health equity and safety

By enrolling minority patients in your studies, you can improve the likelihood that they’ll benefit from the research. The results of the studies will be relevant to more segments of the population, and can help improve access to healthcare services generally, meaning better health equity for everybody. Plus, medical products are safer and more effective for a wider population when clinical research includes diverse populations.

How to design a diverse and inclusive clinical study

Developing relationships with patient advocacy groups is vital to the success of any clinical study. If your study needs to reach an established patient group, or a minority population, then you’ve got to engage community leaders, patient advocates, and key opinion leaders throughout the development process. By developing these relationships with your target population, your study will be welcomed and trusted.

At COUCH Health, we champion the need to improve diversity in clinical studies. Firstly, because we believe that there’s no excuse that this remains an issue in today’s modern world. And secondly, because clinical studies that enrol racially and ethnically diverse patients supports an increase in safe drugs for a representative patient population.

If you’d like to hear more about what we do, or would like to discuss how we could improve diversity and inclusion in your clinical studies, contact us here.

20th July 2020

Share

Tags

Company Details

COUCH Health

+44 (0) 330 995 0656

Contact Website

Address:
Suite 2.10, Jactin House
24 Hood Street
Manchester
M4 6WX
United Kingdom

Latest content on this profile

7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking action’ rather than simply talking about what we should be doing is really important to us. Which is why we put together information that can be used to make change, not just discuss it.
COUCH Health
August 2020: diversity and inclusion in clinical trials round-up
Although the statistics have to change, we’re really pleased that conversations are still happening about the lack of diversity in clinical trials. More reports are coming to light about the lack of ethnicity reporting, and the underrepresentation of ethnic minorities. We hope this evidence and increased awareness will help bring changes not just for individual clinical trials, but across the whole industry.
COUCH Health
If your clinical trial doesn’t have a website, do you even exist?
In a world where pretty much everything and everyone has an online presence, it’s almost unbelievable that not all clinical studies do.
COUCH Health
Site-related factors that can impact patient recruitment
Joining a clinical study is a significant decision for anyone. Before a participant signs up for a clinical study, there are many factors that can influence how likely a patient is to take part. We have previously discussed the importance of patient engagement and the need for patient centricity as early as study planning stages.
COUCH Health
Patient-related factors that can impact patient recruitment
Patient recruitment is, and always will be, a pain point for clinical research companies. It’s potentially the most challenging stage of any clinical study, as unsuccessful recruitment means big delays or failure. But you already know this. It’s why you’re here reading about what factors can impact patient recruitment.
COUCH Health
Protocol-related issues that can impact patient recruitment
Many factors can impact a patient’s decision to take part in a clinical study. But what steps can the industry take to try to improve patient recruitment?  Sometimes, we need to go back to the basics and look to the very beginning of the clinical study process.
COUCH Health